Q1 Fiscal 2018 | Q1 Fiscal 2017 | Year-Over-Year Change | Q4 Fiscal 2017 | Sequential Change | |||||
Revenues | $6.1B | $6.0B | +1% | $5.9B | +3% | ||||
Operating income | $0.0B | $0.8B | (96%) | $0.3B | (91%) | ||||
Net (loss) income 1 | ($6.0B) | $0.7B | N/M | $0.2B | N/M | ||||
Diluted (loss) earnings per share 1 | ($4.03) | $0.46 | N/M | $0.11 | N/M | ||||
Operating cash flow 2 | $1.8B | $1.6B | +11% | $2.4B | (27%) |
Q1 Fiscal 2018 | Q1 Fiscal 2017 | Year-Over-Year Change | Q4 Fiscal 2017 | Sequential Change | |||||
Revenues | $6.0B | $6.0B | +1% | $6.0B | +1% | ||||
Operating income | $1.6B | $2.1B | (21%) | $1.6B | +4% | ||||
Net income | $1.5B | $1.8B | (18%) | $1.4B | +7% | ||||
Diluted earnings per share | $0.98 | $1.19 | (18%) | $0.92 | +7% |
· | The first quarter of fiscal 2018 GAAP results included: |
◦ | $6.0 billion charge, or ($4.03) per share, relating to the enactment of the Tax Cuts and Jobs Act (the Tax Legislation) in the United States (U.S.), which was comprised of $5.3 billion related to the estimated one-time repatriation tax on deemed repatriated earnings and profits of U.S.-owned foreign subsidiaries (the Toll Charge), $562 million resulting from the estimated impact of remeasurement of U.S. deferred tax assets and liabilities that existed at the end of fiscal 2017 at a lower enacted corporate income tax rate and $86 million resulting from our decision to no longer indefinitely reinvest certain foreign earnings. We currently estimate that we will pay $3.3 billion for the Toll Charge, after application of certain tax credits, which is payable in installments over eight years beginning on January 15, 2019. |
◦ | $1.2 billion charge, or ($0.76) per share, for the fine imposed by the European Commission (EC), for which we intend to provide a financial guarantee to satisfy the obligation. |
· | The first quarter of fiscal 2017 GAAP results included: |
◦ | $868 million charge, or ($0.49) per share, for the fine imposed by the Korea Fair Trade Commission (KFTC). |
· | The fourth quarter of fiscal 2017 GAAP results included: |
◦ | $778 million charge, or ($0.52) per share, for the fine imposed by the Taiwan Fair Trade Commission (TFTC), which will be paid in 60 monthly installments beginning on January 30, 2018. |
(in millions except percentages) | Q1 Fiscal 2018 | Q1 Fiscal 2017 | Year-Over-Year Change | Q4 Fiscal 2017 | Sequential Change | ||||
QCT | |||||||||
Revenues | $4,651 | $4,101 | +13% | $4,650 | —% | ||||
EBT 1 | $955 | $724 | +32% | $973 | (2%) | ||||
EBT as % of revenues | 21% | 18% | +3% | 21% | —% | ||||
MSM TM chip shipments | 237 | 217 | +9% | 220 | +8% | ||||
QTL | |||||||||
Revenues | $1,299 | $1,811 | (28%) | $1,213 | +7% | ||||
EBT | $887 | $1,532 | (42%) | $829 | +7% | ||||
EBT as % of revenues | 68% | 85% | (17%) | 68% | —% |
Q2 FY17 Results (1) | Current Guidance Q2 FY18 Estimates (2) | ||||||
Revenues | $5.0B | $4.8B - $5.6B | |||||
Year-over-year change | decrease 4% - increase 12% | ||||||
GAAP diluted earnings per share (EPS) | $0.50 | $0.41 - $0.51 | |||||
Year-over-year change | decrease 18% - increase 2% | ||||||
Less diluted EPS attributable to QSI | $0.00 | $0.03 | |||||
Less diluted EPS attributable to share-based compensation | ($0.14) | ($0.14 | ) | ||||
Less diluted EPS attributable to other items | ($0.69) | ($0.13 | ) | ||||
Non-GAAP diluted EPS | $1.34 | $0.65 - $0.75 | |||||
Year-over-year change | decrease 44% - 51% | ||||||
Other Information | |||||||
MSM chip shipments | 179 | M | 170M - 190M | ||||
Year-over-year change | decrease 5% - increase 6% | ||||||
QTL revenues | $2.2B | $1.15B - $1.35B | |||||
Year-over-year change | decrease 40% - 49% |
(1) | The second quarter of fiscal 2017 GAAP results included a $974 million reduction to revenues, or ($0.48) per share, related to the BlackBerry arbitration decision. Diluted EPS attributable to other items for the second quarter of fiscal 2017 was primarily attributable to the reduction to revenues related to the BlackBerry arbitration decision and acquisition-related items. The second quarter of fiscal 2017 results included QTL revenues related to the products of Apple’s contract manufacturers and the other licensee in dispute. |
(2) | Our financial guidance for the second quarter of fiscal 2018 excludes QTL revenues for royalties due on the sale of Apple’s products by Apple’s contract manufacturers, as well as the sale of products by the other licensee in dispute as we expect the actions taken by these licensees will continue until the respective disputes are resolved. Our guidance for diluted EPS attributable to other items for the second quarter of fiscal 2018 is primarily attributable to acquisition-related items. |
GAAP Results | Less QSI | Less Share-Based Compensation | Less Other Items (a) (b) | Non-GAAP Results | ||||||||||||
Q1 FISCAL 2018 | ||||||||||||||||
Revenues | $6,068 | $30 | $— | $— | $6,038 | |||||||||||
Operating income (loss) | 29 | 9 | (248) | (1,367) | 1,635 | |||||||||||
EBT | (27) | 11 | (248) | (1,373) | 1,583 | |||||||||||
EBT as % of revenues | — | % | 26 | % | ||||||||||||
Net (loss) income | (5,953) | 8 | (199) | (7,230) | 1,468 | |||||||||||
Diluted EPS (c) | ($4.03) | $0.01 | ($0.13) | ($4.89) | $0.98 | |||||||||||
Diluted shares (c) | 1,477 | 1,491 | 1,491 | 1,491 | 1,491 | |||||||||||
Q4 FISCAL 2017 | ||||||||||||||||
Revenues | $5,905 | $43 | $0 | ($95) | $5,957 | |||||||||||
Operating income (loss) | 333 | 22 | (204) | (1,063) | 1,578 | |||||||||||
EBT | 434 | 28 | (204) | (1,065) | 1,675 | |||||||||||
EBT as % of revenues | 7 | % | 28 | % | ||||||||||||
Net income (loss) | 168 | 25 | (153) | (1,079) | 1,375 | |||||||||||
Diluted EPS | $0.11 | $0.02 | ($0.10) | ($0.73) | $0.92 | |||||||||||
Diluted shares | 1,488 | 1,488 | 1,488 | 1,488 | 1,488 | |||||||||||
Q1 FISCAL 2017 | ||||||||||||||||
Revenues | $5,999 | $14 | $— | $— | $5,985 | |||||||||||
Operating income (loss) | 778 | (2) | (239) | (1,054) | 2,073 | |||||||||||
EBT | 870 | (17) | (239) | (1,065) | 2,191 | |||||||||||
EBT as % of revenues | 15 | % | 37 | % | ||||||||||||
Net income (loss) | 682 | (11) | (190) | (900) | 1,783 | |||||||||||
Diluted EPS | $0.46 | ($0.01) | ($0.13) | ($0.60) | $1.19 | |||||||||||
Diluted shares | 1,495 | 1,495 | 1,495 | 1,495 | 1,495 |
(a) | At fiscal year end, the quarterly tax provision (benefit) for each column equals the annual tax provision (benefit) for each column computed in accordance with GAAP. In interim quarters, the sum of these provisions (benefits) may not equal the total GAAP tax provision, and this difference is included in the tax provision (benefit) in the “Other Items” column. See the “Reconciliations of GAAP Tax Rates to Non-GAAP Tax Rates” herein for further details. |
(b) | Further details of amounts included in the “Other Items” column for the current period are included in the “Supplemental Information and Reconciliations” and the “Reconciliations of GAAP Tax Rates to Non-GAAP Tax Rates.” Details of amounts included in the “Other Items” column for prior periods are included in the news releases for those periods. |
(c) | As a result of the net loss in our GAAP results in the first quarter of fiscal 2018, all of the common share equivalents issuable under share-based compensation plans had an anti-dilutive effect and were therefore excluded from the computation of GAAP diluted loss per share. The diluted EPS impacts of the $6.0 billion charge resulting from the Tax Legislation and the $1.2 billion charge related to the fine imposed by the EC were calculated using the GAAP diluted shares. Amounts in all other columns included the common share equivalents issuable under share-based compensation plans in the calculation of diluted earnings per share because the Company reported Non-GAAP net income. |
Q1 FISCAL 2018 | |||||||||||||||||||
($ in millions) | GAAP Results | Less QSI | Less Share-Based Compensation | Less Other Items (a) | Non-GAAP Results | ||||||||||||||
Cost of revenues | $2,663 | $18 | $10 | $106 | $2,529 | ||||||||||||||
Research and development (R&D) expenses | 1,420 | — | 156 | 2 | 1,262 | ||||||||||||||
Selling, general and administrative (SG&A) expenses | 773 | 3 | 82 | 76 | 612 | ||||||||||||||
Other expenses | 1,183 | — | — | 1,183 | — | ||||||||||||||
Interest expense | 170 | — | — | 3 | 167 | ||||||||||||||
Investment and other income, net | 114 | 2 | — | (3) | 115 | (b) |
(a) | Other items excluded from Non-GAAP results included a $1.2 billion charge related to the fine imposed by the EC, $187 million of acquisition-related charges and $3 million of net foreign currency transaction losses related to the TFTC fine. |
(b) | Included $121 million in interest and dividend income and $10 million in net realized gains on investments, partially offset by $12 million in equity in net losses of investees and $4 million in other net investment losses. |
GAAP Results | Less QSI | Less Share-Based Compensation | Less Other Items (c)(d) | Non-GAAP Results | |||||||||||||||||||||||||||
Q1 FISCAL 2018 ($ in millions) | |||||||||||||||||||||||||||||||
Income (loss) before income taxes | $ | (27 | ) | $ | 11 | $ | (248 | ) | $ | (1,373 | ) | $ | 1,583 | ||||||||||||||||||
Income tax (expense) benefit | (5,926 | ) | (3 | ) | 49 | (5,857 | ) | (115 | ) | ||||||||||||||||||||||
Net (loss) income (a) | $ | (5,953 | ) | $ | 8 | $ | (199 | ) | $ | (7,230 | ) | $ | 1,468 | ||||||||||||||||||
Tax rate | (21,948 | %) | 0 | % | (b) | (2 | %) | (b) | (21,953 | %) | (b) | 7 | % | ||||||||||||||||||
FISCAL 2018 ($ in millions) | |||||||||||||||||||||||||||||||
Estimated annual tax rate | 297 | % | 0 | % | (b) | (1 | %) | (b) | 290 | % | (b) | 8 | % |
(a) | Before adjustments for noncontrolling interests. |
(b) | The incremental effect of our adjustments to the Non-GAAP tax rate is calculated by allocating the difference between (i) the tax expense (benefit) calculated based on the GAAP tax rate and (ii) the actual or estimated tax expense (benefit) for each column. |
(c) | In the first quarter of fiscal 2018, tax expense in the “Other Items” column included a $6.0 billion charge resulting from the enactment of the Tax Legislation, partially offset by a $45 million tax benefit to reconcile the tax provision for each column to the total GAAP tax provision for the quarter, a $30 million tax benefit for the tax effect of acquisition-related items in EBT and a $21 million tax benefit for the combined effect of other items in EBT. |
(d) | In fiscal 2018, the estimated annual effective tax rate for the “Other Items” column included a $6.0 billion charge resulting from the enactment of the Tax Legislation, partially offset by a $119 million tax benefit for the tax effect of acquisition-related items in EBT and a $24 million tax benefit for the combined effect of other items in EBT. |
December 24, 2017 | September 24, 2017 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 33,362 | $ | 35,029 | |||
Marketable securities | 2,041 | 2,279 | |||||
Accounts receivable, net | 3,053 | 3,632 | |||||
Inventories | 1,872 | 2,035 | |||||
Other current assets | 638 | 618 | |||||
Total current assets | 40,966 | 43,593 | |||||
Marketable securities | 4,447 | 1,270 | |||||
Deferred tax assets | 1,241 | 2,900 | |||||
Property, plant and equipment, net | 3,224 | 3,216 | |||||
Goodwill | 6,638 | 6,623 | |||||
Other intangible assets, net | 3,548 | 3,737 | |||||
Other assets | 4,287 | 4,147 | |||||
Total assets | $ | 64,351 | $ | 65,486 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Trade accounts payable | $ | 1,685 | $ | 1,971 | |||
Payroll and other benefits related liabilities | 1,041 | 1,183 | |||||
Unearned revenues | 487 | 502 | |||||
Short-term debt | 3,465 | 2,495 | |||||
Other current liabilities | 5,349 | 4,756 | |||||
Total current liabilities | 12,027 | 10,907 | |||||
Unearned revenues | 1,906 | 2,003 | |||||
Income taxes payable | 3,867 | — | |||||
Long-term debt | 19,381 | 19,398 | |||||
Other liabilities | 3,246 | 2,432 | |||||
Total liabilities | 40,427 | 34,740 | |||||
Stockholders’ equity: | |||||||
Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding | — | — | |||||
Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,480 and 1,474 shares issued and outstanding, respectively | 265 | 274 | |||||
Retained earnings | 23,273 | 30,088 | |||||
Accumulated other comprehensive income | 386 | 384 | |||||
Total stockholders’ equity | 23,924 | 30,746 | |||||
Total liabilities and stockholders’ equity | $ | 64,351 | $ | 65,486 |
Three Months Ended | |||||||
December 24, 2017 | December 25, 2016 | ||||||
Revenues: | |||||||
Equipment and services | $ | 4,704 | $ | 4,139 | |||
Licensing | 1,364 | 1,860 | |||||
Total revenues | 6,068 | 5,999 | |||||
Costs and expenses: | |||||||
Cost of revenues | 2,663 | 2,443 | |||||
Research and development | 1,420 | 1,311 | |||||
Selling, general and administrative | 773 | 591 | |||||
Other | 1,183 | 876 | |||||
Total costs and expenses | 6,039 | 5,221 | |||||
Operating income | 29 | 778 | |||||
Interest expense | (170 | ) | (90 | ) | |||
Investment and other income, net | 114 | 182 | |||||
(Loss) income before income taxes | (27 | ) | 870 | ||||
Income tax expense | (5,926 | ) | (189 | ) | |||
Net (loss) income | (5,953 | ) | 681 | ||||
Net loss attributable to noncontrolling interests | — | 1 | |||||
Net (loss) income attributable to Qualcomm | $ | (5,953 | ) | $ | 682 | ||
Basic (loss) earnings per share attributable to Qualcomm | $ | (4.03 | ) | $ | 0.46 | ||
Diluted (loss) earnings per share attributable to Qualcomm | $ | (4.03 | ) | $ | 0.46 | ||
Shares used in per share calculations: | |||||||
Basic | 1,477 | 1,478 | |||||
Diluted | 1,477 | 1,495 | |||||
Dividends per share announced | $ | 0.57 | $ | 0.53 |
Three Months Ended | |||||||
December 24, 2017 | December 25, 2016 | ||||||
Operating Activities: | |||||||
Net (loss) income | $ | (5,953 | ) | $ | 681 | ||
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||||
Depreciation and amortization expense | 363 | 329 | |||||
Indefinite and long-lived asset impairment charges | — | 32 | |||||
Income tax provision in excess of (less than) income tax payments | 5,697 | (113 | ) | ||||
Non-cash portion of share-based compensation expense | 248 | 239 | |||||
Net realized gains on marketable securities and other investments | (23 | ) | (147 | ) | |||
Impairment losses on marketable securities and other investments | 9 | 143 | |||||
Other items, net | 57 | (4 | ) | ||||
Changes in assets and liabilities: | |||||||
Accounts receivable, net | 581 | 131 | |||||
Inventories | 162 | (354 | ) | ||||
Other assets | (56 | ) | (16 | ) | |||
Trade accounts payable | (248 | ) | (208 | ) | |||
Payroll, benefits and other liabilities | 1,000 | 957 | |||||
Unearned revenues | (75 | ) | (84 | ) | |||
Net cash provided by operating activities | 1,762 | 1,586 | |||||
Investing Activities: | |||||||
Capital expenditures | (226 | ) | (129 | ) | |||
Purchases of available-for-sale marketable securities | (5,627 | ) | (4,117 | ) | |||
Proceeds from sales and maturities of available-for-sale securities | 2,704 | 6,891 | |||||
Deposits of investments designated as collateral | — | (1,950 | ) | ||||
Acquisitions and other investments, net of cash acquired | (122 | ) | (57 | ) | |||
Other items, net | 10 | 43 | |||||
Net cash (used) provided by investing activities | (3,261 | ) | 681 | ||||
Financing Activities: | |||||||
Proceeds from short-term debt | 2,116 | 2,727 | |||||
Repayment of short-term debt | (1,149 | ) | (2,727 | ) | |||
Proceeds from issuance of common stock | 134 | 131 | |||||
Repurchases and retirements of common stock | (225 | ) | (444 | ) | |||
Dividends paid | (844 | ) | (784 | ) | |||
Payments of tax withholdings related to vesting of share-based awards | (192 | ) | (172 | ) | |||
Other items, net | (5 | ) | (42 | ) | |||
Net cash used by financing activities | (165 | ) | (1,311 | ) | |||
Effect of exchange rate changes on cash and cash equivalents | (3 | ) | (17 | ) | |||
Net (decrease) increase in cash and cash equivalents | (1,667 | ) | 939 | ||||
Cash and cash equivalents at beginning of period | 35,029 | 5,946 | |||||
Cash and cash equivalents at end of period | $ | 33,362 | $ | 6,885 |
联系客服